Bayer’s Stroke-Prevention Drug Shows Positive Results at Trial

Shares in Bayer rose after the company reported positive results from a clinical trial for an experimental stroke-preventing drug that had previously been shown to be ineffective in another trial.

- By Aimer Look

Bayer's pharmaceutical business has been hit by pressure from drugs going off patent.